Literature DB >> 1489227

Growth hormone deficiency during puberty reduces adult bone mineral density.

S L Hyer1, D A Rodin, J H Tobias, A Leiper, S S Nussey.   

Abstract

Bone mineral density (BMD) was evaluated by dual energy x ray absorptiometry in 60 adults (33 males, 27 females; aged 50, range 23-76 years) who were growth hormone deficient from various causes for 10.4 (1-31) years. Adult patients who had acquired growth hormone deficiency before completion of puberty had significantly reduced mean (SEM) BMD compared with age matched healthy controls at the lumbar spine: 0.87 (0.09) v 1.20 (0.03) g/cm2, femoral neck: 0.81 (0.06) v 1.08 (0.04) g/cm2, and Ward's triangle: 0.68 (0.07) v 1.04 (0.05) g/cm2. These values were also reduced compared with those of patients who had received human growth hormone during puberty. Untreated growth hormone deficiency when present during puberty results in reduced adult bone density.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489227      PMCID: PMC1793978          DOI: 10.1136/adc.67.12.1472

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset.

Authors:  J M Kaufman; P Taelman; A Vermeulen; M Vandeweghe
Journal:  J Clin Endocrinol Metab       Date:  1992-01       Impact factor: 5.958

Review 2.  Endocrine consequences of treatment of malignant disease.

Authors:  S M Shalet
Journal:  Arch Dis Child       Date:  1989-11       Impact factor: 3.791

3.  In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats.

Authors:  E M Spencer; C C Liu; E C Si; G A Howard
Journal:  Bone       Date:  1991       Impact factor: 4.398

4.  Peak trabecular vertebral density: a comparison of adolescent and adult females.

Authors:  V Gilsanz; D T Gibbens; M Carlson; M I Boechat; C E Cann; E E Schulz
Journal:  Calcif Tissue Int       Date:  1988-10       Impact factor: 4.333

5.  Bone mineral status in hypopituitarism.

Authors:  O Arisaka; M Arisaka; A Hosaka; K Yabuta
Journal:  Am J Dis Child       Date:  1989-03

6.  Bone mineral status in growth hormone deficiency.

Authors:  R M Shore; R W Chesney; R B Mazess; P G Rose; G J Bargman
Journal:  J Pediatr       Date:  1980-03       Impact factor: 4.406

Review 7.  Growth hormone (replacement) therapy in adults: bone and calcium metabolism.

Authors:  E A van der Veen; J C Netelenbos
Journal:  Horm Res       Date:  1990

Review 8.  Results of long-term growth hormone replacement therapy in children: when and how to treat?

Authors:  J C Job
Journal:  Horm Res       Date:  1990

9.  Growth response to growth hormone therapy following craniospinal irradiation.

Authors:  P E Clayton; S M Shalet; D A Price
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

10.  Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters.

Authors:  C Glastre; P Braillon; L David; P Cochat; P J Meunier; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

View more
  7 in total

Review 1.  Growth hormone treatment in adults with growth hormone deficiency: the transition.

Authors:  M E Molitch
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

Review 2.  Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: the impact on bone mass.

Authors:  G Saggese; G I Baroncelli; T Vanacore; L Fiore; S Ruggieri; G Federico
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 3.  Skeletal effects of growth hormone and IGF-I in adults.

Authors:  R Marcus
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

Review 4.  Mineral accretion in growing bones--a framework for the future?

Authors:  N J Shaw; N J Bishop
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

Review 5.  A risk-benefit assessment of growth hormone use in children.

Authors:  S L Blethen; M H MacGillivray
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

Review 6.  [Growth hormone therapy in adults. Attempt to assess a decade of use].

Authors:  M Faust; C J Strasburger
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

7.  Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years.

Authors:  Selveta S van Santen; Daniel S Olsson; Marry M van den Heuvel-Eibrink; Mark Wijnen; Casper Hammarstrand; Joseph A M J L Janssen; Gudmundur Johansson; Aart J van der Lely; Sebastian J C M M Neggers
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.